1. Home
  2. GITS vs NVNO Comparison

GITS vs NVNO Comparison

Compare GITS & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GITS

Global Interactive Technologies Inc.

HOLD

Current Price

$2.41

Market Cap

8.8M

Sector

N/A

ML Signal

HOLD

Logo enVVeno Medical Corporation

NVNO

enVVeno Medical Corporation

HOLD

Current Price

$11.05

Market Cap

7.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GITS
NVNO
Founded
2018
1987
Country
South Korea
United States
Employees
12
37
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8M
7.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GITS
NVNO
Price
$2.41
$11.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
35.8K
13.7K
Earning Date
05-19-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$140.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$0.30
52 Week High
$7.09
$12.85

Technical Indicators

Market Signals
Indicator
GITS
NVNO
Relative Strength Index (RSI) 46.83 54.62
Support Level $2.08 $9.78
Resistance Level $2.40 $12.69
Average True Range (ATR) 0.25 0.76
MACD -0.01 -0.03
Stochastic Oscillator 23.29 57.27

Price Performance

Historical Comparison
GITS
NVNO

About GITS Global Interactive Technologies Inc.

Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: